Literature DB >> 17975490

Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis.

Dorothy S Lo1, Robert A Zeldin, Roland Skrastins, Ian M Fraser, Harold Newman, Alan Monavvari, Yee C Ung, Harry Joseph, Teresa Downton, Larissa Maxwell, Jacinta Meharchand.   

Abstract

INTRODUCTION: Multiple investigations often result in a lengthy process from the onset of lung cancer-related symptoms until diagnosis. An unpublished chart audit indicated suboptimal delays in patients' courses from onset of symptoms until diagnosis of cancer.
METHODS: The Time to Treat Program was designed for patients with clinical or radiographic suspicion of lung cancer. Pre- and postimplementation data on median wait times were compared.
RESULTS: From April 2005 to January 2007, 430 patients were referred. After Time to Treat Program implementation, the median time from suspicion of lung cancer to referral for specialist consultation decreased from 20 days to 6 days, and the median time from such referral to the actual consultation date decreased from 17 days to 4 days. The median time from specialist consultation to computed tomography scan decreased from 52 days to 3 days, and the median time from computed tomography scan to diagnosis decreased from 39 days to 6 days. Overall, the median time from suspicion of lung cancer to diagnosis decreased from 128 days to 20 days. Of all patients in the Time to Treat Program, 33% were eventually diagnosed with lung cancer.
CONCLUSIONS: Time to Treat Program was effective in shortening the time from suspicion of lung cancer to diagnosis and reduced time intervals at each step in the process. Earlier diagnosis of lung cancer may allow increased treatment options for patients and may improve outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17975490     DOI: 10.1097/JTO.0b013e318158d4b6

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  22 in total

1.  Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study.

Authors:  Hardeep Singh; Kamal Hirani; Himabindu Kadiyala; Olga Rudomiotov; Traber Davis; Myrna M Khan; Terry L Wahls
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs.

Authors:  Raymond U Osarogiagbon; Richard K Freeman; Mark J Krasna
Journal:  Transl Lung Cancer Res       Date:  2015-08

3.  Implementing a one-day testing model improves timeliness of workup for patients with lung cancer.

Authors:  M A Gulak; C Bornais; S Shin; L Murphy; J Smylie; J R Pantarotto; M Fung-Kee-Fung; D E Maziak
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

4.  Improving Timeliness of Lung Cancer Diagnosis and Staging Investigations Through Implementation of Standardized Triage Pathways.

Authors:  Monica L L Mullin; Audrey Tran; Breanne Golemiec; Christopher J L Stone; Christine Noseworthy; Nicole O'Callaghan; Christopher M Parker; Geneviève C Digby
Journal:  JCO Oncol Pract       Date:  2020-07-08

Review 5.  Guideline for referral of patients with suspected lung cancer by family physicians and other primary care providers.

Authors:  M Elisabeth Del Giudice; Sheila-Mae Young; Emily T Vella; Marla Ash; Praveen Bansal; Andrew Robinson; Roland Skrastins; Yee Ung; Robert Zeldin; Cheryl Levitt
Journal:  Can Fam Physician       Date:  2014-08       Impact factor: 3.275

Review 6.  Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions.

Authors:  Graham W Warren; Kenneth D Ward
Journal:  Transl Lung Cancer Res       Date:  2015-08

7.  Timeliness of care and prognosis in patients with lung cancer.

Authors:  F J Gonzalez-Barcala; J A Falagan; J M Garcia-Prim; L Valdes; J M Carreira; A Puga; P Martín-Lancharro; M T Garcia-Sanz; D Anton-Sanmartin; J C Canive-Gomez; A Pose-Reino; R Lopez-Lopez
Journal:  Ir J Med Sci       Date:  2013-10-04       Impact factor: 1.568

8.  Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?

Authors:  Jeffrey T Yorio; Yang Xie; Jingsheng Yan; David E Gerber
Journal:  J Thorac Oncol       Date:  2009-11       Impact factor: 15.609

9.  Delay to surgical treatment in lung cancer patients and its impact on survival in a video-assisted thoracoscopic lobectomy cohort.

Authors:  Florian Ponholzer; Veronika Kroepfl; Caecilia Ng; Herbert Maier; Florian Kocher; Paolo Lucciarini; Dietmar Öfner; Florian Augustin
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

10.  Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011.

Authors:  J J Ko; R Tudor; H Li; M Liu; K Skolnik; W Kells Boland; J Macklow; D Morris; D G Bebb
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.